GlobalDeal

Alpha 1C

Biotechnology · San Francisco, United States

alpha1c.com

About Alpha 1C

Alpha 1C is a biotechnology company focused on developing innovative therapies for the treatment of Alpha-1 Antitrypsin Deficiency (AATD), a genetic disorder that can lead to serious lung and liver diseases. The company is dedicated to advancing research and providing solutions that improve the quality of life for patients affected by this condition. Alpha 1C aims to leverage cutting-edge science and technology to create effective treatments that address the underlying causes of AATD. Their commitment to patient care and scientific excellence drives their mission to bring new hope to individuals and families impacted by this rare disease.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Genetic Research, Therapeutics, Clinical Trials, Healthcare
Location
San Francisco, United States
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Alpha 1C in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →